Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Cynthia Casson Morton, Ph.D.

Co-Author

This page shows the publications co-authored by Cynthia Morton and Paola Dal Cin.
Connection Strength

2.100
  1. Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24). Genes Chromosomes Cancer. 2003 Feb; 36(2):205-6.
    View in: PubMed
    Score: 0.256
  2. 1q42 approximately q44 is rarely cytogenetically involved in sporadic uterine leiomyomata. Cancer Genet Cytogenet. 2002 Oct 01; 138(1):92-3.
    View in: PubMed
    Score: 0.250
  3. Amplification of AML1 in childhood acute lymphoblastic leukemias. Genes Chromosomes Cancer. 2001 Apr; 30(4):407-9.
    View in: PubMed
    Score: 0.225
  4. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol. 2016 05; 29(5):500-10.
    View in: PubMed
    Score: 0.158
  5. Reporting of diagnostic cytogenetic results. Curr Protoc Hum Genet. 2011 Jul; Appendix 1:1D.
    View in: PubMed
    Score: 0.115
  6. Genomic alterations in myeloid neoplasms with novel, apparently balanced translocations. Cancer Genet. 2011 Feb; 204(2):68-76.
    View in: PubMed
    Score: 0.111
  7. Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma. Genes Chromosomes Cancer. 2010 Dec; 49(12):1152-60.
    View in: PubMed
    Score: 0.110
  8. Reporting of diagnostic cytogenetic results. Curr Protoc Hum Genet. 2010 Oct; Appendix 1:1D.1-23.
    View in: PubMed
    Score: 0.109
  9. Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia. Genes Chromosomes Cancer. 2008 Oct; 47(10):884-9.
    View in: PubMed
    Score: 0.095
  10. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids. Am J Pathol. 2008 May; 172(5):1403-10.
    View in: PubMed
    Score: 0.092
  11. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer. 2006 Mar; 45(3):304-12.
    View in: PubMed
    Score: 0.079
  12. ELF4 is fused to ERG in a case of acute myeloid leukemia with a t(X;21)(q25-26;q22). Leuk Res. 2006 Aug; 30(8):1037-42.
    View in: PubMed
    Score: 0.078
  13. Reporting of diagnostic cytogenetic results. Curr Protoc Hum Genet. 2004 Nov; Appendix 1:Appendix 1D.
    View in: PubMed
    Score: 0.072
  14. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer. 2004 Jun; 40(2):97-108.
    View in: PubMed
    Score: 0.070
  15. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res. 2003 Mar 15; 63(6):1351-8.
    View in: PubMed
    Score: 0.064
  16. Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case. Mod Pathol. 2002 Mar; 15(3):351-6.
    View in: PubMed
    Score: 0.060
  17. Primary parauterine leiomyoma with a t(6;14) Genes Chromosomes Cancer. 1999 Dec; 26(4):385-6.
    View in: PubMed
    Score: 0.051
  18. Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata. Genes Chromosomes Cancer. 1998 Dec; 23(4):361-6.
    View in: PubMed
    Score: 0.048
  19. Reporting of Diagnostic Cytogenetic Results. Curr Protoc Hum Genet. 2016 Apr 01; 89:A.1D.1-A.1D.23.
    View in: PubMed
    Score: 0.040
  20. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res. 2004 Aug 15; 64(16):5570-7.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.